flow trial semaglutide kidney outcomes 2024 Effects of With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Disease: A Prespecified Secondary Analysis flow trial semaglutide kidney outcomes
Description
Conclusion Alcohol is not off-limits on GLP1 medications, but the combination requires more caution than most people realize
GLP-1 receptor agonists like semaglutide and tirzepatide work by slowing digestion and reducing appetite
However, it has become well known for its ability to reduce feelings of hunger
How the combination affects weight loss This is where the conversation gets genuinely exciting
The improved glycemic control provided by GLP-1 agonists smooths these fluctuations, promoting more stable mood throughout the day
Coelentrazine-h (Yeasen Biotech) was added to a final concentration of 5 M for 5 min before bioluminescence resonance energy transfer (BRET) readings were made using an EnVision plate reader (PerkinElmer)
